This on-demand activity is part of the Pharmacist to Pharmacist Buprenorphine Resource Initiative for Dispensing Guidance and Education (P2P BRIDGE) series. The goal of this webinar is to help Kentucky Pharmacists and Pharmacy Technicians learn more about barriers that patients with opioid use disorder (OUD) face when obtaining buprenorphine treatment and explore ways they can support patients. After participating in this activity, learners will understand the importance of patient-centered care in the treatment of OUD in pharmacy practice.
This webinar is a recording of a live broadcast presented on September 8, 2024. Participants who claimed CE for the live broadcast are not eligible to claim CE credit for the recorded webinar.
|
This ACPE-accredited continuing pharmacy education activity (0022-0000-24-007-H08-P/T) is designed to meet the Kentucky Board of Pharmacy continuing education regulatory requirement for pharmacists to complete 1 hour of CPE on the opioid epidemic or opioid use disorder as outlined in 201 KAR 2:0 |
Faculty
![]() Monica F. Roberts, PharmD
Academic Detailing Pharmacist
University of Kentucky
Lexington, KY
|
|
Monica F. Roberts, PharmD, is an academic detailing pharmacist with experience providing education to physicians, pharmacists, and dentists. She developed and delivered the prescription opioid safety educational outreach program for the University of Kentucky’s HEALing Communities Study. Dr. Roberts graduated from the University of Kentucky College of Pharmacy in 2017 and completed the University of Kentucky College of Pharmacy Community Pharmacy Residency Program with the Kroger Louisville Division in 2018. She has over 6 years’ experience working in various roles in community pharmacies. Prior to her pharmacy career, she worked in journalism and publishing as a copy editor, page designer, and technical writer. |
|
Content Reviewer
Courtney Eatmon, PharmD, BCPP
Clinical Pharmacist Practitioner, Substance Use Disorders
Lexington VA Health Care System
Lexington, KY
|
Disclosures
None of the planners, authors, reviewers, or others in control of educational content for this activity have any relevant financial relationships with ineligible companies to disclose.
Learning Objectives
- Recognize common barriers patients overcome to obtain buprenophine treatment for opioid use disorder (OUD).
- Describe the pharmacy's role in supporting patients on their individual journey to OUD remission and recovery.
- Develop ways to promote patient-centered care in the treatment of OUD in pharmacy practice.
Agenda
- On-demand Webinar Presentation (50 min)
- Post-test and Evaluation (10 min)
Requirements for CE Credit
To claim credit for this activity, participants must:
1. Watch the on-demand webinar in its entirety
2. Pass the post-test with a score of 70% or higher
3. Complete the activity evaluation
Upon successful completion participant CE credit will be directly uploaded to CPE Monitor.
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Application
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)

The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Support
The Buprenorphine Resource Initiative for Dispensing Guidance and Education (BRIDGE) is funded by a grant from the Foundation for Opioid Response Efforts (https://forefdn.org). For more information regarding P2P BRIDGE visit https://p2p.uky.edu/bridge.
System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 10 or higher, macOS Sierra (10.12) or higher
- Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Microsoft Edge, Safari 9 or higher
- Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
- Media Viewing Requirements: Adobe Reader, HTML5
Click to view our privacy policy
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, legal/regulatory issues and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice. Activities accredited by the University of Kentucky College of Pharmacy are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Kentucky College of Pharmacy.
For questions regarding this activity, please contact the UK CoP Continuing Professional Development Office at pharmacyCPD@uky.edu